Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aponte

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|November 17, 2025
Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 studyRobert W Frenck, Abdi Naficy, Jodi Feser, et al.
Lancet (London, England)|September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trialsJohn J Aponte, David Schellenberg, Andrea Egan, et al.
Plos One|December 1, 2018
Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomalleiSylvia R Trevino, Christopher P Klimko, Matthew C Reed, et al.
Malaria Journal|August 7, 2015
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity ratesGloria P Gómez-Pérez, Almudena Legarda, Jose Muñoz, et al.
Cell Death & Disease|June 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Malaria Journal|May 16, 2025
Consistency and reproducibility of independent feedings using blood from two consecutive days at varying Plasmodium falciparum gametocyte densities based on both direct membrane feeding assay and direct skin feeding assayHoseah Miima Akala, John J Aponte, Millicent Anyango Achola, et al.
The Lancet. Infectious Diseases|September 7, 2015
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialMichael T White, Robert Verity, Jamie T Griffin, et al.
The Lancet. Healthy Longevity|July 9, 2021
A call for standardised age-disaggregated health dataTheresa Diaz, Kathleen L Strong, Bochen Cao, et al.
The New England Journal of Medicine|October 22, 2015
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineD E Neafsey, M Juraska, T Bedford, et al.
The New England Journal of Medicine|October 20, 2011
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|November 17, 2025
Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 studyRobert W Frenck, Abdi Naficy, Jodi Feser, et al.
Lancet (London, England)|September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trialsJohn J Aponte, David Schellenberg, Andrea Egan, et al.
Plos One|December 1, 2018
Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomalleiSylvia R Trevino, Christopher P Klimko, Matthew C Reed, et al.
Malaria Journal|August 7, 2015
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity ratesGloria P Gómez-Pérez, Almudena Legarda, Jose Muñoz, et al.
Cell Death & Disease|June 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Malaria Journal|May 16, 2025
Consistency and reproducibility of independent feedings using blood from two consecutive days at varying Plasmodium falciparum gametocyte densities based on both direct membrane feeding assay and direct skin feeding assayHoseah Miima Akala, John J Aponte, Millicent Anyango Achola, et al.
The Lancet. Infectious Diseases|September 7, 2015
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialMichael T White, Robert Verity, Jamie T Griffin, et al.
The Lancet. Healthy Longevity|July 9, 2021
A call for standardised age-disaggregated health dataTheresa Diaz, Kathleen L Strong, Bochen Cao, et al.
The New England Journal of Medicine|October 22, 2015
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineD E Neafsey, M Juraska, T Bedford, et al.
The New England Journal of Medicine|October 20, 2011
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Pageof 19